• Profile
Close

Choroidal neovascularization secondary to photodynamic therapy for central serous chorioretinopathy: Incidence, risk factors, and clinical outcomes

Retina Aug 01, 2021

Hwang S, Noh H, Kang SW, et al. - In this retrospective consecutive interventional study, researchers sought to examine the incidence, risk factors, and clinical outcomes of complicated choroidal neovascularization (CNV) after reduced-fluence photodynamic therapy (PDT) for central serous chorioretinopathy. Participants in the study were 520 patients (559 eyes) treated by reduced-fluence PDT for central serous chorioretinopathy. Reduced-fluence PDT for central serous chorioretinopathy may be complicated by CNV in approximately 1% of cases, which can be well controlled with anti-vascular endothelial growth factor injection. Secondary CNV after PDT is increased by flat irregular pigment epithelial detachment.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay